Here's Why Credit Suisse Sees Tesla Triumph Amid Odds
Credit Suisse analyst Dan Levy maintained Tesla Inc (NASDAQ: TSLA) with an Outperform and cut the price target from $1,125 to $1,000 (37% upside).
Levy expected Tesla's 2Q deliveries of 242,000, missing the consensus of ~280,000 due to the Shanghai COVID shutdown.
Moreover, given the lower delivery outlook, the associated margin impact, and an expected Bitcoin impairment, he reduced the 2Q EPS estimate to $1.10 from $2.06, below the consensus of $2.08.
Nevertheless, he remained positive on Tesla, as the long-term fundamentals were intact. He noted that the widening supply constraints would likely extend Tesla's lead over other OEMs in the race to EVs.
Levy expected the robust fundamentals ahead should outweigh the near-term challenges for Tesla, like the recent growth sell-off, production disruptions in China, lingering semiconductor shortage, and magnified inflationary pressures.
He believed the long-term case for Tesla was evident.
Tesla remained the global leader in EVs amid rising supply chain risks.
Tesla's lead in vertical integration and prior EV experience amplified its lead over other automakers in the race to EV.
Levy reaffirmed his Outperform rating and remained positive on the stock. The Price Target cut reflected a higher discount rate.
Price Action: TSLA shares traded higher by 4.06% at $733.87 on the last check Friday.
Latest Ratings for TSLA
Date | Firm | Action | From | To |
---|---|---|---|---|
Feb 2022 | Daiwa Capital | Upgrades | Neutral | Outperform |
Feb 2022 | Piper Sandler | Maintains | Overweight | |
Jan 2022 | Credit Suisse | Upgrades | Neutral | Outperform |
View More Analyst Ratings for TSLA
View the Latest Analyst Ratings
See more from Benzinga
Tesla Supplier Challenges EV Maker's Powerful Battery With Latest Launch
Chinese Analyst Provokes Country To Attack Elon Musk's Popular Starlink Satellite Service
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.